The genomic model was trained on the Cerebras Wafer Scale Cluster in the Cerebras cloud. The results were achieved by combining publicly available human reference genome data with Mayo's comprehensive patient exome data.
1 Billion
Parameters
10x larger than AlphaFold
1 Trillion
Tokens
Leveraging Mayo’s
in-house patient data
Highest Accuracy for Clinical Evals
Outperforms today's best models
Combining AI and domain expertise
to produce better patient outcomes
"Mayo is committed to fundamentally transforming healthcare by using the most advanced AI technology. We’ve been able to develop AI tools with such promise in less than a year, in part, because of our collaboration with Cerebras that enabled us to create this state-of-the-art AI model for genomics."
Matthew Callstrom, MD, PhD
Medical Director for Strategy, Chair - Dept. of Radiology

“It is an honor to collaborate with Mayo Clinic, the top-ranked hospital in the nation. With its recognized leadership in delivering medical outcomes, we are uniquely positioned to combine AI and medicine. The state-of-the-art AI models we are developing together will work alongside doctors to help with patient diagnosis, treatment planning, and outcome estimation.”
Andrew Feldman
CEO and co-founder, Cerebras

This new state-of-the-art foundation model for genomics achieves unprecedented accuracy in disease prediction
Cancer Predisposing
Cardiovascular Predisposing
Drug Response for Rheumatoid Arthritis
Unlock the power of AI for your organization

Cerebras And Mayo Clinic Announce Foundation Model For Healthcare

Cerebras Systems teams with Mayo Clinic on genomic model that predicts arthritis treatment

Cerebras Systems and Mayo Clinic Unveil Best in Class Genomic Foundation Model

Cerebras Systems and Mayo Clinic Unveil Best in Class Genomic Foundation Model
